van der Kooij M A, von der Mark E M, Kruijt J K, van Velzen A, van Berkel T J, Morand O H
Pharma Division, Hoffmann-La Roche Ltd, Basel, Switzerland.
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3107-16. doi: 10.1161/01.atv.17.11.3107.
A protein that specifically binds oxidized LDL (Ox-LDL) has recently been characterized in mouse peritoneal macrophages and identified as macrosialin, a protein with a molecular weight of 95 kD. First, the present work shows that human monocyte-derived macrophages express a membrane protein with a molecular weight of approximately 120 kD that selectively binds Ox-LDL. Second, we tested whether this approximately 120-kD Ox-LDL binding protein had any relation to CD68, the human homologue of macrosialin. The following evidence was obtained to support the role of CD68 as an Ox-LDL binding protein: (1) Ligand blots with Ox-LDL and Western blots with Ki-M6, an anti-human CD68 monoclonal antibody, revealed a single band with a molecular weight of approximately 120 kD under reducing and nonreducing condition. (2) The expression patterns of the approximately 120-kD Ox-LDL binding membrane protein and of CD68 paralleled each other during monocyte/macrophage differentiation. (3) Digestion with N-glycosidase F demonstrated that both CD68 and the Ox-LDL binding protein are glycoproteins; both showed a similar shift of approximately 18 kD in apparent molecular weight. (4) CD68, probed with monoclonal antibody Ki-M6, and the approximately 120-kD Ox-LDL binding protein were coprecipitated with EMB11, another anti-CD68 antibody. About 5000 molecules of CD68 are expressed on the cell surface of human macrophages. Ligation of 125I-Ki-M6 to cells leads to its internalization and degradation. This capacity would be sufficient to allow for the specific uptake and degradation of Ox-LDL. Taken together, these data support a role for CD68 as a specific Ox-LDL binding protein in human monocyte-derived macrophages.
最近在小鼠腹腔巨噬细胞中发现了一种能特异性结合氧化型低密度脂蛋白(Ox-LDL)的蛋白质,它被鉴定为巨唾液酸蛋白,分子量为95 kD。首先,本研究表明,人单核细胞衍生的巨噬细胞表达一种分子量约为120 kD的膜蛋白,该蛋白能选择性结合Ox-LDL。其次,我们检测了这种约120 kD的Ox-LDL结合蛋白是否与巨唾液酸蛋白的人类同源物CD68有关。获得了以下证据来支持CD68作为Ox-LDL结合蛋白的作用:(1)用Ox-LDL进行的配体印迹和用抗人CD68单克隆抗体Ki-M6进行的蛋白质印迹显示,在还原和非还原条件下,均出现一条分子量约为120 kD的条带。(2)在单核细胞/巨噬细胞分化过程中,约120 kD的Ox-LDL结合膜蛋白和CD68的表达模式相互平行。(3)用N-糖苷酶F消化表明,CD68和Ox-LDL结合蛋白均为糖蛋白;两者在表观分子量上均出现了约18 kD的相似变化。(4)用单克隆抗体Ki-M6检测的CD68和约120 kD的Ox-LDL结合蛋白与另一种抗CD68抗体EMB11共沉淀。人巨噬细胞的细胞表面表达约5000个CD68分子。将125I-Ki-M6与细胞连接会导致其内化和降解。这种能力足以实现Ox-LDL的特异性摄取和降解。综上所述,这些数据支持CD68作为人单核细胞衍生巨噬细胞中一种特异性Ox-LDL结合蛋白的作用。